Skip to main content
SpringerLink
Log in

An Evidence-based Approach to Familial Nonmedullary Thyroid Cancer: Screening, Clinical Management, and Follow-up

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Approximately 5% of nonmedullary thyroid cancers are of familial origin. When two or more family members are diagnosed with nonmedullary thyroid cancer in the absence of other known associated syndromes it is termed familial nonmedullary thyroid cancer (FNMTC). The genetic inheritance of FNMTC remains unknown, but it is believed to be an autosomal dominant mode of inheritance with incomplete penetrance and variable expressivity. FNMTC has been shown to be more aggressive and to have a worse prognosis than sporadic nonmedullary thyroid cancer. For example, studies have demonstrated that individuals with FNMTC have an increased risk of multifocal disease, local invasion, and lymph node metastases. These aggressive features appear to contribute to the higher recurrence rate and decreased disease-free survival seen in FNMTC patients compared to those with sporadic differentiated thyroid cancer. This article is an overview of the literature available in the English language discussing FNMTC. Critical questions regarding the screening, management, and follow-up of these patients are addressed with answers proposed based on the available literature. The quality of the evidence is ranked according to Sackett’s criteria. Overall, the literature quality is somewhat limited, based on the low prevalence of FNMTC, the difficulty in identifying familial cases, the variable study designs, and limited long-term follow-up. Conclusions: To date, the optimal clinical approach is yet to be established, but improved awareness and screening will permit earlier detection, more timely intervention, and hopefully improved outcomes for patients and their families.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106–130

    Article  PubMed  Google Scholar 

  2. Loh KC. Familial nonmedullary thyroid carcinoma: a meta-review of case series. Thyroid 1997;7:107–113

    Article  CAS  PubMed  Google Scholar 

  3. Hemminki K, Li X. Familial risk of cancer by site and histopathology. Int J Cancer 2003;103:105–109

    Article  CAS  PubMed  Google Scholar 

  4. Alsanea O, Clark OH. Familial thyroid cancer. Curr Opin Oncol 2001;13:44–51

    Article  CAS  PubMed  Google Scholar 

  5. Fischer DK, Groves MD, Thomas SJ Jr, et al. Papillary carcinoma of the thyroid: additional evidence in support of a familial component. Cancer Invest 1989;7:323–325

    Article  CAS  PubMed  Google Scholar 

  6. Stoffer SS, Van Dyke DL, Bach JV, et al. Familial papillary carcinoma of the thyroid. Am J Med Genet 1986;25:775–782

    Article  CAS  PubMed  Google Scholar 

  7. Pal T, Vogl FD, Chappuis PO, et al. Increased risk for nonmedullary thyroid cancer in the first-degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 2001;86:5307–5312

    Article  CAS  PubMed  Google Scholar 

  8. Grossman RF, Tu SH, Duh QY, et al. Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 1995;130:892–897; discussion 898–899

    CAS  PubMed  Google Scholar 

  9. Uchino S, Noguchi S, Kawamoto H, et al. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 2002;26:897–902

    Article  PubMed  Google Scholar 

  10. Kwok CG, McDougall IR. Familial differentiated carcinoma of the thyroid: report of five pairs of siblings. Thyroid 1995;5:395–397

    Article  CAS  PubMed  Google Scholar 

  11. Robinson D, Orr T. Carcinoma of the thyroid and other diseases of the thyroid in identical twins. Arch Surg 1955;70:923–928

    CAS  Google Scholar 

  12. Goldgar DE, Easton DF, Cannon-Albright LA, et al. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600–1608

    Article  CAS  PubMed  Google Scholar 

  13. Ron E, Kleinerman RA, LiVolsi VA, et al. Familial nonmedullary thyroid cancer. Oncology 1991;48:309–311

    Article  CAS  PubMed  Google Scholar 

  14. Charkes ND. On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds. Thyroid 2006;16:181–186

    Article  PubMed  Google Scholar 

  15. Charkes ND. On the prevalence of familial nonmedullary thyroid cancer. Thyroid 1998;8:857–858

    Article  CAS  PubMed  Google Scholar 

  16. Triponez F, Wong M, Sturgeon C, et al. Does familial non-medullary thyroid cancer adversely affect survival? World J Surg 2006;30:787–793

    Article  PubMed  Google Scholar 

  17. Maxwell EL, Hall FT, Freeman JL. Familial non-medullary thyroid cancer: a matched-case control study. Laryngoscope 2004;114:2182–2186

    Article  PubMed  Google Scholar 

  18. Canzian F, Amati P, Harach HR, et al. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 1998;63:1743–1748

    Article  CAS  PubMed  Google Scholar 

  19. Cetta F, Montalto G, Gori M, et al. Germline mutations of the APC gene in patients with familial adenomatous polyposis-associated thyroid carcinoma: results from a European cooperative study. J Clin Endocrinol Metab 2000;85:286–292

    Article  CAS  PubMed  Google Scholar 

  20. Sturgeon C, Clark OH. Familial nonmedullary thyroid cancer. Thyroid 2005;15:588–593

    Article  PubMed  Google Scholar 

  21. Hemminki K, Eng C, Chen B. Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 2005;90:5747–5753

    Article  CAS  PubMed  Google Scholar 

  22. Brunaud L, Zarnegar R, Wada N, et al. Chromosomal aberrations by comparative genomic hybridization in thyroid tumors in patients with familial nonmedullary thyroid cancer. Thyroid 2003;13:621–629

    Article  CAS  PubMed  Google Scholar 

  23. Burgess JR, Duffield A, Wilkinson SJ, et al. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid. J Clin Endocrinol Metab 1997;82:345–348

    Article  CAS  PubMed  Google Scholar 

  24. Lupoli G, Vitale G, Caraglia M, et al. Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 1999;353:637–639

    Article  CAS  PubMed  Google Scholar 

  25. Musholt TJ, Musholt PB, Petrich T, et al. Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg 2000;24:1409–1417

    Article  CAS  PubMed  Google Scholar 

  26. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1989;95(2 Suppl):2S–4S

    Article  CAS  PubMed  Google Scholar 

  27. Segal K, Friedental R, Lubin E, et al. Papillary carcinoma of the thyroid. Otolaryngol Head Neck Surg 1995;113:356–363

    Article  CAS  PubMed  Google Scholar 

  28. DeGroot LJ, Kaplan EL, McCormick M, et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414–424

    Article  CAS  PubMed  Google Scholar 

  29. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61:978–996

    CAS  PubMed  Google Scholar 

  30. Nikiforova MN, Stringer JR, Blough R, et al. Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells. Science 2000;290:138–1341

    Article  CAS  PubMed  Google Scholar 

  31. Houlston RS, Stratton MR. Genetics of non-medullary thyroid cancer. Q J Med 1995;88:685–693

    CAS  Google Scholar 

  32. Alsanea O, Wada N, Ain K, et al. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery 2000;128:1043–1050; discussion 1050–1051

    Article  CAS  PubMed  Google Scholar 

  33. Miura D, Wada N, Chin K, et al. Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization. Thyroid 2003;13:283–290

    Article  CAS  PubMed  Google Scholar 

  34. Nishiyama RH. Another dissertation on poorly differentiated carcinomas: is it really necessary? Adv Anat Pathol 1999;6:281–286

    Article  CAS  PubMed  Google Scholar 

  35. Franceschi S, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999;10:583–595

    Article  CAS  PubMed  Google Scholar 

  36. Bevan S, Pal T, Greenberg CR, et al. A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR, and TRKA in familial nonmedullary thyroid cancer: confirmation of linkage to TCO1. J Clin Endocrinol Metab 2001;86:3701–3704

    Article  CAS  PubMed  Google Scholar 

  37. Tucker MA, Boice JD Jr, Hoffman DA. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935–82. Natl Cancer Inst Monogr 1985;68:161–189

    CAS  PubMed  Google Scholar 

  38. Uchino S, Noguchi S, Yamashita H, et al. Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma. World J Surg 2004;28:1099–1102

    Article  PubMed  Google Scholar 

  39. Takami H, Ozaki O, Ito K. Familial nonmedullary thyroid cancer: an emerging entity that warrants aggressive treatment. Arch Surg 1996;131:676

    CAS  PubMed  Google Scholar 

  40. Leprat F, Bonichon F, Guyot M, et al. Familial non-medullary thyroid carcinoma: pathology review in 27 affected cases from 13 French families. Clin Endocrinol (Oxf) 1999;50:589–594

    Article  CAS  Google Scholar 

  41. Vriens MR, Sabanci U, Epstein HD, et al. Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer. Thyroid 1999;9:1011–1016

    Article  CAS  PubMed  Google Scholar 

  42. Bignell GR, Canzian F, Shayeghi M, et al. Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet 1997;61:1123–1130

    Article  CAS  PubMed  Google Scholar 

  43. McKay JD, Lesueur F, Jonard L, et al. Localization of a susceptibility gene for familial nonmedullary thyroid carcinoma to chromosome 2q21. Am J Hum Genet 2001;69:440–446

    Article  CAS  PubMed  Google Scholar 

  44. Learoyd DL, Messina M, Zedenius J, et al. Molecular genetics of thyroid tumors and surgical decision-making. World J Surg 2000;24:923–933

    Article  CAS  PubMed  Google Scholar 

  45. Malchoff CD, Sarfarazi M, Tendler B, et al. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome. J Clin Endocrinol Metab 2000;85:1758–1764

    Article  CAS  PubMed  Google Scholar 

  46. Lesueur F, Stark M, Tocco T, et al. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. J Clin Endocrinol Metab 1999;84:2157–2162

    Article  CAS  Google Scholar 

  47. Xing M. The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol (Oxf) 2005;63:263–266

    Article  CAS  Google Scholar 

  48. Mazzaferri EL. Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol 1987;14:315–332

    CAS  PubMed  Google Scholar 

  49. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990;19:545–576

    CAS  PubMed  Google Scholar 

  50. Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998;133:419–425

    Article  CAS  PubMed  Google Scholar 

  51. Skinner MA, Moley JA, Dilley WG, et al. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 2005;353:1105–1113

    Article  CAS  PubMed  Google Scholar 

  52. Machens A, Niccoli-Sire P, Hoegel J, et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003;349:1517–1525

    Article  CAS  PubMed  Google Scholar 

  53. Zarnegar R, Brunaud L, Clark OH. Prevention, evaluation, and management of complications following thyroidectomy for thyroid carcinoma. Endocrinol Metab Clin North Am 2003;32:483–502

    Article  PubMed  Google Scholar 

Download references

ACKNOWLEDGMENTS

This work was supported in part by Friends of Endocrinology, the Gerald Heller Family Foundation, and the Helen and Sanford Diller Foundation.

Author information

Authors and Affiliations

  1. University of California San Francisco Department of Surgery, UCSF Comprehensive Cancer Center at Mount Zion, z1600 Divisidero Street, Hellman Building, Room C-347, San Francisco, California

    Rebecca S. Sippel MD & Orlo H. Clark MD

  2. Northern Medical Group, University of Northern British Columbia, 3333 University Way, Prince George, British Columbia, V2N 429, Canada

    Nadine R. Caron MD

Authors
  1. Rebecca S. Sippel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nadine R. Caron MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Orlo H. Clark MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Orlo H. Clark MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sippel, R.S., Caron, N.R. & Clark, O.H. An Evidence-based Approach to Familial Nonmedullary Thyroid Cancer: Screening, Clinical Management, and Follow-up. World J Surg 31, 924–933 (2007). https://doi.org/10.1007/s00268-006-0847-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-006-0847-1

Keywords

Search

Navigation